Enhertu Snub From England’s NICE Not ‘In Line’ With Other Countries

Outlier
NICE's decision on Enhertu is different from that of many other countries • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Market Access

More from Pink Sheet